ROCHESTER, Minnesota — Mayo Clinic researchers have developed organoid models to study uveal melanoma, one of the most common types of eye cancer in adults. Their goal is to use these ...
The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...
Prognostic significance of pigmentation and stem cell markers in Indian population of uveal melanoma
Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal ...
The updated NCCN Guidelines now include HEPZATO KIT as a Category 2A treatment option for patients with hepatic-dominant uveal melanoma. Previously, the guidelines limited its use to patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback